FDA

The Apple Heart Study — which began enrollment at the end of November — has now begun data collection, with participants receiving prompts over the weekend to sign informed consent documents and initiate data collection.

Healthcare was a much anticipated topic in President Donald Trump’s State of the Union address — in fact, a Politico poll showed that 82 percent of Americans wanted to hear the president address the healthcare system over other divisive discussion points.

Last week, we published part 1 of our digital health trends and predictions piece, covering big picture trends like vertical integration and healthcare consumerization, as well as some of the buzzy tech trends of voice, AI, and blockchain.

Nokia has announced that it will disable the pulse wave velocity measurement feature on its Withings’ Body Cardio scale as of January 24.

Last September, Tidepool — a diabetes data management platform — was among the nine companies chosen to participate in the FDA’s experimental pre-certification program pilot.

Updated with statement from Eli Lilly Indianapolis-based pharma company Eli Lilly recently recieved FDA 510K clearance for a new mobile app called Go Dose, a diabetes management and insulin dosing app for users of Humalog, Lilly's rapid-acting insulin.

Last November, as part of an investigative series on Apple's meetings with the FDA, we reported the company's stated plans to develop "two possible (and related) products in the cardiac space" which would require FDA clearance.

Health enterprise SaaS company Welltok announced an expanded partnership with IBM Watson Health.

IBM Watson Health has announced a joint initiative with the US Food and Drug Administration to study the use of blockchain technology to share health data to ultimately improve public health.

Over the past year, MobiHealthNews has covered 36 devices that received clearance from the Food and Drug Administration.